Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
The role of histone lysine demethylases in cancer cells' resistance to tyrosine kinase inhibitorsJasmine Cassar White, Perla Pucci, Francesco Crea
Trends in Pharmacological Sciences|June 13, 2018
Hypoxia and Noncoding RNAs in Taxane ResistancePerla Pucci, Pasquale Rescigno, Semini Sumanasuriya, et al.
Discover Oncology|February 24, 2022
Deep analysis of neuroblastoma core regulatory circuitries using online databases and integrated bioinformatics shows their pan-cancer roles as prognostic predictorsLeila Jahangiri, Perla Pucci, Tala Ishola, et al.
Epigenomics|October 22, 2021
<i>HAR1</i>: an insight into lncRNA genetic evolutionElla Waters, Perla Pucci, Mark Hirst, et al.
Epigenomics|July 4, 2020
LncRNA <i>HORAS5</i> promotes taxane resistance in castration-resistant prostate cancer via a BCL2A1-dependent mechanismPerla Pucci, Erik Venalainen, Ilaria Alborelli, et al.
Cancers|April 3, 2021
The Role of Autophagy and lncRNAs in the Maintenance of Cancer Stem CellsLeila Jahangiri, Tala Ishola, Perla Pucci, et al.
International Journal of Molecular Sciences|August 27, 2021
The Contribution of Autophagy and LncRNAs to MYC-Driven Gene Regulatory Networks in CancersLeila Jahangiri, Perla Pucci, Tala Ishola, et al.
The Prostate|July 24, 2019
T-type calcium channels drive the proliferation of androgen-receptor negative prostate cancer cellsRoberto Silvestri, Perla Pucci, Erik Venalainen, et al.
Molecular Oncology|February 19, 2019
The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional programAbhijit Parolia, Erik Venalainen, Hui Xue, et al.
Cancers|January 11, 2022
BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCLGavin D Garland, Stephen P Ducray, Leila Jahangiri, et al.
Pageof 2